ID   KKU-M055
AC   CVCL_M258
SY   KKUM055; M055; KKU-055
DR   DepMap; ACH-001537
DR   JCRB; JCRB1551
DR   Wikidata; Q54900004
RX   PubMed=15884115;
RX   PubMed=18714155;
RX   PubMed=21871105;
RX   PubMed=22926522;
RX   PubMed=31077409;
RX   PubMed=35640676;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): JCRB
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 7,8
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 15
//
RX   PubMed=15884115; DOI=10.3748/wjg.v11.i18.2748;
RA   Tepsiri N., Chaturat L., Sripa B., Namwat W., Wongkham S.,
RA   Bhudhisawasdi V., Tassaneeyakul W.;
RT   "Drug sensitivity and drug resistance profiles of human intrahepatic
RT   cholangiocarcinoma cell lines.";
RL   World J. Gastroenterol. 11:2748-2753(2005).
//
RX   PubMed=18714155; DOI=10.1159/000151541;
RA   Namwat N., Amimanan P., Loilome W., Jearanaikoon P., Sripa B.,
RA   Bhudhisawasdi V., Tassaneeyakul W.;
RT   "Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell
RT   lines.";
RL   Chemotherapy 54:343-351(2008).
//
RX   PubMed=21871105; DOI=10.1186/1476-4598-10-102;
RA   Obchoei S., Weakley S.M., Wongkham S., Wongkham C., Sawanyawisuth K.,
RA   Yao Q.-Z., Chen C.-Y.;
RT   "Cyclophilin A enhances cell proliferation and tumor growth of liver
RT   fluke-associated cholangiocarcinoma.";
RL   Mol. Cancer 10:102.1-102.15(2011).
//
RX   PubMed=22926522; DOI=10.1038/onc.2012.382;
RA   Kunkeaw N., Jeon S.H., Lee K., Johnson B.H., Tanasanvimon S.,
RA   Javle M., Pairojkul C., Chamgramol Y., Wongfieng W., Gong B.,
RA   Leelayuwat C., Lee Y.S.;
RT   "Cell death/proliferation roles for nc886, a non-coding RNA, in the
RT   protein kinase R pathway in cholangiocarcinoma.";
RL   Oncogene 32:3722-3731(2013).
//
RX   PubMed=31077409; DOI=10.1002/hep.30704;
RA   Sittithumcharee G., Suppramote O., Vaeteewoottacharn K.,
RA   Sirisuksakun C., Jamnongsong S., Laphanuwat P., Suntiparpluacha M.,
RA   Matha A., Chusorn P., Buraphat P., Kakanaporn C., Charngkaew K.,
RA   Silsirivanit A., Korphaisarn K., Limsrichamrern S., Tripatara P.,
RA   Pairojkul C., Wongkham S., Sampattavanich S., Okada S.,
RA   Jirawatnotai S.;
RT   "Dependency of cholangiocarcinoma on cyclin D-dependent kinase
RT   activity.";
RL   Hepatology 70:1614-1630(2019).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//